Human mesenchymal stem cell (hMSC) homing is the migration of endogenous and exogenous hMSCS to the target organs and the subsequent colonization under the action chemotaxic factors. This is an important process involved in the repair of damaged tissues. However, we know little about the mechanism of hMSC homing. Stromal cell derived factor-1 (SDF-1) is a cytokine secreted by stromal cells. Its only receptor CXCR4 is widely expressed in blood cells, immune cells and cells in the central nervous system. SDF-1/CXCR4 signaling pathway plays an important role in hMSC homing and tissue repair. Human cbll1 gene encodes E3 ubiquitin-protein ligase Hakai (also known as CBLL1) consisting of RING-finger domain that is involved in ubiquitination, endocytosis and degradation of epithelial cadherin (E-cadherin) as well as in the regulation of cell proliferation. We successfully constructed LV3-CXCR4 siRNA lentiviral vector, LV3-CBLL1 RNAi lentiviral vector and the corresponding cell systems which were used to induce hMSC homing in the presence of SKOV3 cells. Thus the mechanism of hMSC homing was studied.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340663PMC

Publication Analysis

Top Keywords

hmsc homing
20
human mesenchymal
8
mesenchymal stem
8
stem cell
8
skov3 cells
8
mechanism hmsc
8
lentiviral vector
8
homing
6
cells
6
cell
5

Similar Publications

miR-29a-3p orchestrates key signaling pathways for enhanced migration of human mesenchymal stem cells.

Cell Commun Signal

July 2024

Department of Medical Sciences, General Graduate School, Soon Chun Hyang University, Asan, 31538, Republic of Korea.

Article Synopsis
  • - The study focuses on the importance of human mesenchymal stem cells (hMSCs) migration for their therapeutic use and investigates the regulatory role of certain microRNAs, particularly miR-29a-3p, in enhancing this migration.
  • - Experimental methods included expressing miR-29a-3p in hMSCs, analyzing various signaling pathways, and performing multiple migration assays, which revealed that silencing DGCR8 (a key miRNA biogenesis component) hindered hMSC migration.
  • - Overexpressing miR-29a-3p significantly improved hMSC migration by inhibiting crucial phosphatases and stabilizing essential cellular structures, ultimately increasing the hMSCs' ability to move towards chemo
View Article and Find Full Text PDF
Article Synopsis
  • * In a study, it was found that the microRNAs miR-9-5p and miR-221-3p encourage the movement of human MSCs towards hepatocyte growth factor (HGF), resulting in better engraftment and reduced liver damage compared to regular MSCs.
  • * Overexpressing these microRNAs not only inhibited hepatic stellate cell activation but also decreased levels of fibrogenic and inflammatory factors, indicating a potential strategy to enhance MSC therapies for liver injuries through microRNA modification. *
View Article and Find Full Text PDF

Human multipotent mesenchymal stromal cells (hMSCs) are of significant therapeutic interest due to their ability to deliver oncolytic adenoviruses to tumors. This approach is also investigated for targeting head and neck squamous cell carcinomas (HNSCCs). HAdV-5-HexPos3, a recently reported capsid-modified vector based on human adenovirus type 5 (HAdV-5), showed strongly improved infection of both hMSCs and the HNSCC cell line UM-SCC-11B.

View Article and Find Full Text PDF
Article Synopsis
  • Human mesenchymal stem cells (hMSCs) have great potential in regenerative medicine, but their ability to migrate to injury sites is not very effective.
  • Research found that silica nanoparticles (SiO-NPs) can temporarily block autophagy, leading to an increase in CXCR4 receptors on hMSCs, which helps them migrate more effectively towards SDF1α, a key chemotactic factor.
  • The study suggests that using SiO-NPs can enhance hMSC migration to injury sites, potentially improving the success of stem cell therapies.
View Article and Find Full Text PDF

Selective targeting of transfected mesenchymal stem cells (MSCs) carrying specific antioncogenes to the tumor was suggested as a treatment option. Bone morphogenetic protein-2 (BMP2) was shown to inhibit the proliferation and aggressiveness of osteosarcoma (OS) cells. Here, we aimed to assess the homing efficiency of intraperitoneally administered hMSCs transfected with to the tumoral site and their effects on OS using an orthotopic xenograft murine model.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!